Acute kidney injury following HCT: Incidence, risk factors and outcome

Bone Marrow Transplantation

Volumn 46, Issue 11, 2011, Pages 1399-1408

  Lopes, J A ^a   Jorge, S ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

acute kidney injury; HCT; myeloablative; nonmyeloablative

Indexed keywords

CYCLOSPORIN A; PREDNISOLONE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; CHRONIC KIDNEY DISEASE; DEHYDRATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; LIVER VENOOCCLUSIVE DISEASE; MYELOABLATIVE CONDITIONING; NEPHROTOXICITY; NONMYELOABLATIVE CONDITIONING; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; SURVIVAL TIME; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUBULAR DYSFUNCTION; UREMIA; VIRUS REACTIVATION;

ACUTE KIDNEY INJURY; CYCLOSPORINE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INCIDENCE; MYELOABLATIVE AGONISTS; RISK FACTORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 80855143796     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.46     Document Type: Review

References (96)

1. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750-758.
2. Childs R, Srinivasan R. Advances in allogeneic stem cell transplantation: Directing graft-versus-leukemia at solid tumors. Cancer J 2002; 8: 2-11.
3. Uzunel M, Mattsson J, Brune M, Johansson JE, Aschan J, Ringden O. Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation. Blood 2003; 101: 469-472. (Pubitemid 36077566)
4. Schattenberg AV, Levenga TH. Differences between the different conditioning regimens for allogeneic stem cell transplantation. Curr Opin Oncol 2006; 18: 667-670. (Pubitemid 44427645)
5. Dey BR, Spitzer TR. Current status of haploidentical stem cell transplantation. Br J Haematol 2006; 135: 423-437. (Pubitemid 44583409)
6. Hermann S, Klein SA, Jacobi V, Thalhammer A, Bialleck H, Duchscherer M et al. Older patients with high-risk fungal infections can be successfully allografted using nonmyeloablative conditioning in combination with intensified supportive care regimens. Br J Haematol 2001; 113: 446-454. (Pubitemid 32523154)
7. Saito T, Kanda Y, Kami M, Kato K, Shoji N, Kanai S et al. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. Clin Cancer Res 2002; 8: 1014-1020. (Pubitemid 35177350)
8. Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM et al. Low-dose total body irradiation (TBI) and fludarabine followed by haematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with haematologic diseases. Blood 2003; 101: 1620-1629. (Pubitemid 36182543)
9. Blaise D, Bay JO, Faucher C, Michallet M, Boiron J-M, Choufi B et al. Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. Blood 2004; 103: 435-441. (Pubitemid 38140070)
10. Belkacemi Y, Labopin M, Hennequin C, Hoffstetter S, Mungai R, Wygoda M et al. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation. Int J Radiat Oncol Biol Phys 2007; 67: 544-551. (Pubitemid 46108301)
11. Zager RA, O'Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM et al. Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients. Am J Kidney Dis 1989; 13: 210-216. (Pubitemid 19087543)
12. Merouani A, Shpall E, Jones R, Archer P, Schrier RW. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int 1996; 50: 1026-1031. (Pubitemid 26302694)
13. Gruss E, Bernis C, Tomas JF, Garcia-Canton C, Figuera A, Motellón JL et al. Acute renal failure in patients following bone marrow transplantation: Prevalence, risk factors and outcome. Am J Nephrol 1995; 15: 473-479.
14. Parikh CR, McSweeney PA, Korular D, Ecder T, Merouani A, Taylor J et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 2002; 62: 566-573. (Pubitemid 34779769)
15. Hahn T, Rondeau C, Shaukat A, Jupudy V, Miller A, Alam AR et al. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 2003; 32: 405-410. (Pubitemid 37038850)
16. Hingorani SR, Guthrie K, Batchelder A, Schoch G, Aboulhosn N, Manchion J et al. Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors. Kidney Int 2005; 67: 272-277. (Pubitemid 40019249)
17. Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 2005; 45: 502-509. (Pubitemid 40341329)
18. Kersting S, Koomans HA, Hené RJ, Verdonck LF. Acute renal failure after allogeneic myeloablative stem cell transplantation: Retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 2007; 39: 359-365. (Pubitemid 46403928)
19. Lopes JA, Jorge S, Silva S, de Almeida E, Abreu F, Martins C et al. Acute renal failure following myeloablative autologous and allogeneic haematopoietic cell transplantation. Bone Marrow Transplant 2006; 38: 707. (Pubitemid 44669689)
20. Ando M, Mori J, Ohashi K, Akiyama H, Morito T, Tsuchiya K et al. A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT. Bone Marrow Transplant 2010; 45: 1427-1434.
21. Hosing C, Nash R, McSweeney P, Mineishi S, Seibold J, Griffith LM et al. Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. Biol Blood Marrow Transplant 2010. (e-pub ahead of print).
22. Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M et al. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int 2003; 63: 1868-1873. (Pubitemid 36513335)
23. Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE, Cizman B. Nephrotic syndrome after hematopoietic cell transplantation: Do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 2006; 1: 685-694.
24. Reddy P, Johnson K, Uberti JP, Reynolds C, Silver S, Ayash L et al. Nephrotic syndrome associated with chronic graftversus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 351-357.
25. Kusumi E, Kami M, Hara S, Hoshino J, Yamaguchi Y, Murashige N et al. Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: Possible involvement of graft-versus-host disease. Int J Hematol 2008; 87: 225-230.
26. Kersting S, Dorp SV, Theobald M, Verdonck LF. Acute renal failure after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant 2008; 14: 125-131. (Pubitemid 350286747)
27. Lopes JA, Gonçalves S, Jorge S, Raimundo M, Resende L, Lourenço F et al. Contemporary analysis of the influence of the acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival. Bone Marrow Transplant 2008; 42: 619-626.
28. Giralt S, Thall PF, Khouri I, Wang X, Brauschweig I, Ippolitti C et al. Melphalan and purine analog-containing preparative regimens: Reduced intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631-637. (Pubitemid 32113394)
29. Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant 2000; 6: 309-320.
30. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 1998; 91: 756-763. (Pubitemid 28078275)
31. Burt RK, Traynor A, Statkute L, BarrWG, Rosa R, Schroeder J et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295: 527-553.
32. Maris M, Sandmaier BM, Maloney DG, McSweeney PA, Woolfrey A, Chauncey T et al. Nonmyeloablative haematopoietic stem cell transplantation. Transfus Clin Biol 2001; 8: 231-234. (Pubitemid 32672979)
33. Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before haematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550-1558. (Pubitemid 39166537)
34. Parikh CR, Sandmaier BM, Storb RF, Blume KG, Sahebi F, Maloney DG et al. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol 2004; 15: 1868-1876. (Pubitemid 38822066)
35. Liu H, Ding J-H, Lu B-C, Zhao G, Chen B-A. Early renal injury after nonmyeloablative alloegenic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia. Am J Nephrol 2007; 27: 336-341. (Pubitemid 47077197)
36. Parikh CR, Yarlagadda SG, Storer B, Sorror M, Storb R, Sandmaier B. Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14: 309-315. (Pubitemid 351218200)
37. Piñana JL, Valcá rcel D, Martino R, Barba P, Moreno E, Sureda A et al. Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience. Biol Blood Marrow Transplant 2009; 15: 21-29.
38. Liu H, Li Y-F, Liu B-C, Ding J-H, Chen B-A, Xu W-L, Qian J. A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT. Bone Marrow Transplant 2010; 45: 153-158.
39. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004; 114: 795-804. (Pubitemid 39578738)
40. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370. (Pubitemid 46179340)
41. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Beginning Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294: 813-818.
42. McDonald GB, Hinds MS, Fisher LD. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267. (Pubitemid 23046384)
43. Fink JC, Cooper MA, Burkhart KM, McDonald GB, Zager RA. Marked enzymuria after bone marrow transplantation: A correlate of veno-occlusive disease-induced 'hepatorenal syndrome'. J Am Soc Nephrol 1995; 6: 1655-1660.
44. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994; 46: 1443-1458. (Pubitemid 24330726)
45. Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int 2006; 69: 430-435. (Pubitemid 43164432)
46. Dulley FL, Kanfer EJ, Appelbaum FR, Amos D, Hill RS, Buckner CD et al. Venoocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987; 43: 870-873. (Pubitemid 17084267)
47. Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol 2003; 23: 465-476. (Pubitemid 37176692)
48. Kopp JB, Klotman PE. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1990; 1: 162-179.
49. De Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressant drugs: Long-term consequences and challenges for the future. Am J Kidney Dis 2000; 35: 333-346. (Pubitemid 30070861)
50. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481-508.
51. Lamas S. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors. Kidney Int 2005; 68: 898-907. (Pubitemid 43323151)
52. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RS, Ring S et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323: 693-699. (Pubitemid 20288937)
53. Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD. Chronic kidney disease after hematopoietic cell transplantation: A systematic review. Am J Transplant 2008; 8: 2378-2390.
54. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285. (Pubitemid 15087125)
55. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
56. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N, European Uremic Toxin Work Group. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056.
57. Weiss AS, Sandmaier BM, Storer B, Storb R, McSweeney PA, Parikh CR. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006; 6: 89-94. (Pubitemid 43382205)
58. Delgado J, Cooper N, Thomson K, Duarte R, Jarmulowicz M, Cassoni A et al. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 75-83. (Pubitemid 43034100)
59. Kersting S, Hené RJ, Koomans HA, Verdonck LF. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 1169-1175. (Pubitemid 47413012)
60. Kersting S, Verdonck LF. Chronic kidney disease after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant 2008; 14: 403-408. (Pubitemid 351372743)
61. Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14: 658-663. (Pubitemid 351664061)
62. Kersting S, Verdonck LF. Stem cell transplantation nephropathy: A report of six cases. Biol Blood Marrow Transplant 2007; 13: 638-643. (Pubitemid 46768003)
63. Dieterle A, Gratwohl A, Nizze H, Huser B, Mihatsch MJ, Thiel G et al. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients. Transplantation 1990; 49: 1093-1100. (Pubitemid 20227633)
64. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA et al. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995; 6: 1186-1196.
65. Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N et al. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int 1999; 55: 674-685. (Pubitemid 29082894)
66. Shihab FS, Bennett WM, Tanner AM, Andoh TF. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 1997; 52: 660-673. (Pubitemid 27402364)
67. Islam M, Burke Jr. JF, McGowan TA, Zhu Y, Dunn SR, McCue P et al. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int 2001; 59: 498-506. (Pubitemid 32157915)
68. Hauser IA, Schaeffeler E, Gauer S, Scheuermann EH, Wegner B, Gossmann J et al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporinerelated nephrotoxicity after renal transplantation. J Am Soc Nephrol 2005; 16: 1501-1511. (Pubitemid 41716536)
69. Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998; 53: 897-908. (Pubitemid 28155662)
70. Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: Role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009; 4: 345-353.
71. Hébert MJ, Fish D, Madore F, Bélanger R, Nolin L, Dandavino R et al. Mesangiolysis associated with bone marrow transplantation: New insights on possible etiogenic factors. Am J Kidney Dis 1994; 23: 882-883. (Pubitemid 24173576)
72. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma. Transfusion 2004; 44: 294-304. (Pubitemid 38236394)
73. Cruz DN, Perazella MA, Mahnensmith RL. Bone marrow transplant nephropathy: A case report and review of the literature. J Am Soc Nephrol 1997; 8: 166-173. (Pubitemid 27496527)
74. Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: Prevalence and risk factors. Nephrol Dial Transplant 2010; 25: 278-282.
75. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
76. Hingorani S, Guthrie KA, Schoch G,Weiss NS,McDonald GB. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007; 39: 223-229.
77. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 2001; 10: 785-792. (Pubitemid 33043673)
78. Schwartz G, Brion L, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediat Clin N Am 1987; 34: 571-590. (Pubitemid 17080631)
79. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: F887-F899.
80. Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure. A potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 2004; 13: 1-7.
81. Burne-Taney MJ, Liu M, Ascon D, Molls RR, Racusen L, Rabb H. Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naiäve mice: A possible mechanism linking early injury and progressive renal disease? Am J Physiol Renal Physiol 2006; 291: F981-F986. (Pubitemid 44772031)
82. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223-228.
83. Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordoñez JD et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009; 76: 893-899.
84. Hoffmeister PA, Hingorani SR, Storer BE, Baker KS, Sanders JE. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 16: 515-524.
85. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006; 17: 2034-2047. (Pubitemid 44036188)
86. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006; 10: R73.
87. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study. Crit Care 2005; 9: R700-R709.
88. Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J et al. Acute kidney injury in patients with sepsis: A contemporary analysis. Int J Infect Dis 2009; 13: 176-181.
89. Lopes JA, Fernandes P, Jorge S, Resina C, Santos C, Pereira A et al. Long-term risk of mortality after acute kidney injury in patients with sepsis: A contemporary analysis. BMC Nephrol 2010; 11: 9.
90. Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008; 168: 987-995. (Pubitemid 351679639)
91. Covic A, Schiller A, Mardare NG, Petrica L, Petrica M, Mihaescu A et al. The impact of acute kidney injury on shortterm survival in an Eastern European population with stroke. Nephrol Dial Transplant 2008; 23: 2228-2234. (Pubitemid 351957576)
92. Tsagalis G, Akrivos T, Alevizaki M, Manios E, Theodorakis M, Laggouranis A et al. Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol 2009; 4: 616-622.
93. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1549-1558. (Pubitemid 36687056)
94. Hassoun HT, Lie ML, Grigoryev DN, Liu M, Tuder RM, Rabb H. Kidney ischemia-reperfusion injury induces caspasedependent pulmonary fibrosis. Am J Physiol Renal Physiol 2009; 1: F125-F137.
95. Li X, Hassoun HT, Santora R, Rabb H. Organ crosstalk: The role of the kidney. Curr Opin Crit Care 2009; 15: 481-487.
96. Lopes JA, Jorge S, Gonçalves S, Resina C, Silva S, de Almeida E et al. Contemporary analysis of the influence of acute kidney injury (AKI) after myeloablative hematopoietic cell transplantation on long-term patient's survival. Bone Marrow Transplant 2008; 42: 139-141.